Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
metabolic drugs
Biotech
OrbiMed-backed Pinnacle adds $89M for oral peptides
The funds will fuel Pinnacle's preclinical pipeline through early clinical testing, with a focus on immunology and cardiometabolic indications.
Darren Incorvaia
Mar 26, 2026 10:29am
Zealand pens $2.5B cardiometabolic collab with Chinese biotech
Dec 11, 2025 5:45am
Lilly pens $1.2B pact with Sanegene to target metabolic RNA meds
Nov 10, 2025 4:05am
Barinthus enters reverse merger with metabolic disease biotech
Sep 30, 2025 10:39am
Biomea cuts staff, drops leukemia asset in metabolic shift
May 5, 2025 6:59pm
Novo taps Photys for multi-molecule cardiometabolic collab
Dec 18, 2024 7:30am
